Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Blood Glucose Test Strip Market Research Report Information by Technology (Thick Film Electrochemical, Thin Film Electrochemical, Optical) - Forecast to 2030


ID: MRFR/MED/0390-CR | 110 Pages | Author: Kinjoll Dey| June 2016
Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 INTRODUCTION

1.1 DEFINITION 9

1.2 SCOPE OF THE STUDY 9

1.2.1 RESEARCH OBJECTIVE 9

1.2.2 ASSUMPTIONS 9

1.2.3 LIMITATIONS 10

1.3 MARKET STRUCTURE 10

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS 11

2.2 PRIMARY RESEARCH 11

2.3 SECONDARY RESEARCH 11

2.4 MARKET SIZE ESTIMATION 12

2.5 FORECAST MODEL 12

3 FORECAST INDICATORS

3.1 GROWTH DRIVERS 13

3.1.1 CONVENIENCE OF SELF BLOOD GLUCOSE MONITORING OVER TRADITIONAL METHODS 13

3.1.2 TECHNOLOGICAL ADVANCEMENTS 14

3.1.3 RISING DIABETIC POPULATION 14

3.1.4 PLAYERS ENGAGED IN CREATINGAWARENESS REGARDING REGULAR BLOOD GLUCOSE MONITORING 15

3.1.5 GOVERNMENT INITIATIVES TO PROPEL AUSTRALIAN BLOOD GLUCOSE TEST STRIP MARKET 15

3.1.6 RISING DISPOSABLE INCOME OF EMERGING ECONOMIES 16

3.2 GROWTH BARRIERS 17

3.2.1 INADEQUATE REIMBURSEMENT FOR TEST STRIPS 17

3.2.2 LOW ADOPTION OF SMBG IN EMERGING ECONOMIES AS COMPARED TO DEVELOPED REGIONS 17

3.2.3 ADVENT OF GENERIC BLOOD GLUCOSE TEST STRIPS 17

3.3 OPPORTUNITIES 18

3.3.1 EMERGING ECONOMIES 18

4 GLOBAL BLOOD GLUCOSE TEST STRIP MARKET

5 BLOOD GLUCOSE TEST STRIP MARKET, BY TECHNOLOGY

6 BLOOD GLUCOSE TEST STRIP MARKET, BY REGION

6.1 NORTH AMERICA 24

BLOOD GLUCOSE TEST STRIP MARKET, BY TECHNOLOGY

6.2 EUROPE 28

BLOOD GLUCOSE TEST STRIP MARKET, BY TECHNOLOGY

6.3 ASIA-PACIFIC 31

BLOOD GLUCOSE TEST STRIP MARKET, BY TECHNOLOGY

6.4 LATIN AMERICA 35

BLOOD GLUCOSE TEST STRIP MARKET, BY TECHNOLOGY

6.5 MIDDLE EAST & AFRICA 37

BLOOD GLUCOSE TEST STRIP MARKET, BY TECHNOLOGY

7 COMPETITIVE LANDSCAPE

7.1 PRODUCTION CAPACITY 41

7.2 MARKET SHARE ANALYSIS 42

7.2.1 GLOBAL 42

7.2.2 NORTH AMERICA 43

7.2.3 EUROPE 44

7.2.4 ASIA-PACIFIC 44

7.2.5 LATIN AMERICA, MIDDLE EAST, AND AFRICA 45

7.3 COMPARATIVE ANALYSIS 49

7.3.1 COMPARATIVE ANALYSIS: KEY PLAYERS 49

8 COMPANY PROFILES

8.1 ABBOTT LABORATORIES 50

8.1.1 BUSINESS OVERVIEW 50

8.1.2 FINANCIALS 51

8.1.3 PRODUCT PORTFOLIO 51

8.1.4 DEVELOPMENTS 51

8.2 ROCHE DIAGNOSTICS 52

8.2.1 BUSINESS OVERVIEW 52

8.2.2 FINANCIALS 52

8.2.3 PRODUCT PORTFOLIO 53

8.2.4 DEVELOPMENTS 53

8.3 LIFESCAN, INC. (A JOHNSON & JOHNSON COMPANY) 54

8.3.1 BUSINESS OVERVIEW 54

8.3.2 FINANCIALS (J&J) 54

8.3.3 PRODUCT PORTFOLIO 55

8.3.4 DEVELOPMENT 55

8.4 I-SENS, INC. 56

8.4.1 BUSINESS OVERVIEW 56

8.4.2 FINANCIALS 56

8.4.3 PRODUCT PORTFOLIO 57

8.4.4 DEVELOPMENT 57

8.5 TRIVIDIA HEALTH (PREVIOUSLY KNOWN AS NIPRO DIAGNOSTICS, INC.) 58

8.5.1 BUSINESS OVERVIEW 58

8.5.2 FINANCIALS 58

8.5.3 PRODUCT PORTFOLIO 59

8.5.4 DEVELOPMENTS 59

8.6 ASCENSIA DIABETES CARE HOLDINGS AG (PREVIOUSLY KNOWN AS BAYER DIABETES CARE) 60

8.6.1 BUSINESS OVERVIEW 60

8.6.2 FINANCIALS 60

8.6.3 PRODUCT PORTFOLIO 61

8.6.4 DEVELOPMENTS 61

8.7 APEX BIOTECHNOLOGY CORPORATION 62

8.7.1 BUSINESS OVERVIEW 62

8.7.2 FINANCIALS 62

8.7.3 PRODUCT PORTFOLIO 63

8.7.4 DEVELOPMENTS 63

8.8 AGAMATRIX INC 64

8.8.1 BUSINESS OVERVIEW 64

8.8.2 FINANCIALS 64

8.8.3 PRODUCT PORTFOLIO 64

8.8.4 DEVELOPMENTS 64

8.9 TAIDOC TECHNOLOGY CORPORATION 65

8.9.1 BUSINESS OVERVIEW 65

8.9.2 FINANCIALS 65

8.9.3 PRODUCT PORTFOLIO 65

8.9.4 DEVELOPMENTS 65

8.10 UNIVERSAL BIOSENSORS 66

8.10.1 BUSINESS OVERVIEW 66

8.10.2 FINANCIALS 66

8.10.3 PRODUCT PORTFOLIO 67

8.10.4 DEVELOPMENTS 67

8.11 BEIJING YICHENG ELECTRONIC CO., LTD. 68

8.11.1 BUSINESS OVERVIEW 68

8.11.2 FINANCIALS 68

8.11.3 PRODUCT PORTFOLIO 68

8.11.4 DEVELOPMENTS 68

8.12 SANNUO BIOSENSOR INC. 69

8.12.1 BUSINESS OVERVIEW 69

8.12.2 FINANCIALS 69

8.12.3 PRODUCT PORTFOLIO 69

8.12.4 DEVELOPMENTS 69

8.13 SHANGHAI MICROSENSE TM INC. 70

8.13.1 BUSINESS OVERVIEW 70

8.13.2 FINANCIALS 70

8.13.3 PRODUCT PORTFOLIO 70

8.13.4 DEVELOPMENTS 70

8.14 ACON LABORATORIES, INC. 71

8.14.1 BUSINESS OVERVIEW 71

8.14.2 FINANCIALS 71

8.14.3 PRODUCT PORTFOLIO 71

8.14.4 DEVELOPMENTS 72

8.15 ALLMEDICUS 73

8.15.1 BUSINESS OVERVIEW 73

8.15.2 FINANCIALS 73

8.15.3 PRODUCT PORTFOLIO 73

8.15.4 DEVELOPMENTS 73

8.16 NATIONAL DIAGNOSTIC PRODUCTS 74

8.16.1 BUSINESS OVERVIEW 74

8.16.2 FINANCIALS 74

8.16.3 PRODUCT PORTFOLIO 74

8.16.4 DEVELOPMENTS 74

8.17 HMD BIOMEDICAL 75

8.17.1 BUSINESS OVERVIEW 75

8.17.2 FINANCIALS 75

8.17.3 PRODUCT PORTFOLIO 75

8.17.4 DEVELOPMENTS 75

8.18 YUWELL-JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. 76

8.18.1 BUSINESS OVERVIEW 76

8.18.2 FINANCIALS 76

8.18.3 PRODUCT PORTFOLIO 76

8.18.4 DEVELOPMENTS 76

8.19 77 ELEKTRONIKA KFT. 77

8.19.1 BUSINESS OVERVIEW 77

8.19.2 FINANCIALS 77

8.19.3 PRODUCT PORTFOLIO 77

8.19.4 DEVELOPMENTS 77

8.20 B. BRAUN MELSUNGEN AG 78

8.20.1 BUSINESS OVERVIEW 78

8.20.2 FINANCIALS 78

8.20.3 PRODUCT PORTFOLIO 79

8.20.4 DEVELOPMENTS 79

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.